FDA grants RMAT designation to RiboX’s RXRG001 for xerostomia

RXRG001 is a proprietary circular RNA therapy encoding human aquaporin-1, a protein involved in fluid transport. Credit: Krisana Antharith / Shutterstock.com.



  • FDA RiboX Therapeutics